10 Best SPACs to Buy According to David Einhorn’s Greenlight Capital
In this article, we discuss the 10 best SPACs to buy according to David Einhorn's Greenlight Capital.
Posts Tagged ‘NYSE:FRX’
Actavis plc (ACT), Time Warner Inc (TWX), Canadian Pacific Railway Limited (USA) (CP): Billionaire Daniel Och’s Top Picks
Daniel S. Och’s OZ Management is among the investment management firms required to disclose their long equity positions once per quarter.
Icahn Enterprises LP (IEP), eBay Inc (EBAY), Netflix Inc. (NFLX), Gannett Co. Inc. (GCI): Carl Icahn’s Recent Portfolio Activity
Legendary corporate raider Carl Icahn recently filed his second quarter Form 13F with the SEC.
Actavis plc (ACT), Tableau Software Inc. (DATA), Forest Laboratories Inc. (FRX): GLG Partners Loves These Stocks
In its latest 13F filing, GLG Partners, managed by Noam Gottesman, disclosed equity position as held at the end of June, 2014.
Beam Suntory Inc. (BEAM). Hudson City Bancorp, Inc. (HCBK): Jane Mendillo Justifies Harvard’s Decision to Diversify Its Portfolio by Investing in Non U.S Equities
Harvard Management Company Chief Executive Officer, Jane Mendillo, shared her investment philosophy on CNBC, during an interactive program which was held on the sidelines of...
Deepak Gulati’s Argentiere Capital is Bullish on Foster Wheeler AG (FWLT) & Time Warner Cable Inc (TWC)
Deepak Gulati is the former head of global equity proprietary trading at JPMorgan Chase & Co.
Mario Gabelli, GAMCO Investors’ Biggest Equity Portfolio Moves During the First Quarter
Mario Gabelli's GAMCO Investors is one of the most prominent funds in the investment universe, which is why we consider that its activity should be followed closely, especially...
Kenneth Squire’s 13D Management Is Betting on These Stocks
13D Management is a New-York firm that was founded by Kenneth Squire in 2011. The fund, an event driven asset manager, focused on imitating activist investors.
Nehal Chopra’s Ratan Capital is Betting on These Stocks
Nehal Chopra is a graduate from the Wharton School of the University of Pennsylvania.
Billionaire Carl Icahn’s Top Picks At the End of 2013
In its latest 13F, Icahn Capital, managed by billionaire Carl Icahn, reported its equity portfolio held at the end of September 2013.
Dr. Reddy’s Laboratories Limited (ADR) (RDY), Abbott Laboratories (ABT): Positive Outlook for the Generic Version of Depakote ER
Since 1983, Depakote ER has been a good source of revenue for drug manufacturers. The drug is mainly used in the treatment of bipolar disorder, migraines, and seizures.
Carl Icahn News Trends: Apple Inc. (AAPL) Shares, Twitter Movement, Dell Inc. (DELL) & More
Activist investor Carl Icahn said he bought more shares of Apple Inc. (NASDAQ:AAPL) on Wednesday as the company's stock price slid.
Raptor Pharmaceutical Corp. (RPTP), Mylan Inc. (MYL), Forest Laboratories, Inc. (FRX): Will You Adopt This Orphan Drug?
Orphan drug status, which is given to drugs meant for the treatment of rare diseases, offers drug developers a path to faster approval and enhanced market exclusivity.
Johnson & Johnson (JNJ), Forest Laboratories, Inc. (FRX), Pfizer Inc. (PFE): Pharmas Spending the Most to Catch Your Doctor’s Eye
Pharmaceutical firms spend a lot of money to influence physicians to prescribe their products.
Is Novo Nordisk A/S (ADR) (NVO) Going to Burn These Hedge Funds?
In the 21st century investor’s toolkit, there are a multitude of metrics investors can use to track Mr. Market.
What Hedge Funds Think About Pharmacyclics, Inc. (PCYC)
In today’s marketplace, there are many metrics market participants can use to track publicly traded companies.
Alkermes Plc (ALKS), Eli Lilly & Co. (LLY), AstraZeneca plc (ADR) (AZN): Tackling Pain and Addiction
Alkermes Plc (NASDAQ:ALKS) is primarily known for its schizophrenia and multiple sclerosis drug treatments.
Allergan, Inc. (AGN): Hedge Funds Are Bullish and Insiders Are Undecided, What Should You Do?
In the eyes of many of your fellow readers, hedge funds are seen as useless, old financial vehicles of an era lost to time.
Forest Laboratories, Inc. (FRX): Hedge Funds Aren’t Crazy About It, Insider Sentiment Unchanged
If you were to ask many investors, hedge funds are seen as delayed, old financial tools of an era lost to time.
Pfizer Inc. (PFE), Eli Lilly & Co. (LLY), Forest Laboratories, Inc. (FRX): The Past, Present, and Future of Alzheimer’s Treatments
Editor’s Note: A previous version of this post incorrectly stated that Eli Lilly’s experimental drug solanezumab is a BACE inhibitor.
Who’s Dumping Teva Pharmaceutical Industries Ltd (ADR) (TEVA)?
Like most pharma companies, Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA)'s stock price generally trades akin to the actions of a roller coaster.
Valeant Pharmaceuticals Intl Inc (VRX), GlaxoSmithKline plc (ADR) (GSK) – CAPScall of the Week: Raptor Pharmaceutical Corp. (RPTP)
For years, satirical late-night TV host Stephen Colbert has been running a series on his show called "Better Know a District," which highlights one of the 435 U.S.
Osiris Therapeutics, Inc. (OSIR), GlaxoSmithKline plc (ADR) (GSK), Forest Laboratories, Inc. (FRX): This Week in Biotech
With the SPDR S&P Biotech Index up 34% over the trailing-12-month period, it's evident that investment dollars are willingly flowing into the biotech sector.
Facebook Inc (FB), Forest Laboratories, Inc. (FRX): 7 Stocks Set To Surge On Secret Earnings Pattern
Second-quarter earnings season was a bit of a bust. Although earnings remain at an all-time high, the pace of earnings growth continues to look weak.
Cubist Pharmaceuticals Inc (CBST), Forest Laboratories, Inc. (FRX): Marketed Drugs, Strong Pipeline, Long Term Growth Stock
In June this year, a drug candidate from Cubist Pharmaceuticals Inc (NASDAQ:CBST) received fast track status from the FDA.
Array Biopharma Inc (ARRY), Vertex Pharmaceuticals Incorporated (VRTX): This Week in Biotech
With the SPDR S&P Biotech Index up 29% over the trailing-12-month period, it's evident that investment dollars are willingly flowing into the biotech sector.
Google Inc (GOOG), Apple Inc. (AAPL)- Stateless Income: What It Means for the Stocks You Own
With taxes having risen for most people at the beginning of 2013, ordinary Americans are increasingly angry about the steps that many well-known U.S.
Is Forest Laboratories, Inc. (FRX) Destined for Greatness?
Investors love stocks that consistently beat the Street without getting ahead of their fundamentals and risking a meltdown.
Elan Corporation, plc (ADR) (ELN), VIVUS, Inc. (VVUS), MannKind Corporation (MNKD): Three Biotech Companies to Watch This Summer
The news flow from biotech companies might slow down during the summer, but it won't stop.
Amarin Corporation plc (ADR) (AMRN): This Drugmaker Should Go Fishing for a Marketing Partner
The biotechnology sector is rapidly evolving, and what was a near-guarantee of success of getting a drug approved by the Food and Drug Administration 10 years ago is no longer...
Is Pharmacyclics, Inc. (PCYC) Going to Burn These Hedge Funds?
To most shareholders, hedge funds are perceived as unimportant, outdated investment vehicles of years past.
Forest Laboratories, Inc. (FRX): Are Hedge Funds Right About This Stock?
Forest Laboratories, Inc. (NYSE:FRX) was in 35 hedge funds' portfolio at the end of March.
Ironwood Pharmaceuticals, Inc. (IRWD), Forest Laboratories, Inc. (FRX): Three Horrendous Healthcare Stocks This Past Week
Gloom, despair, and agony. Shareholders of at least three health-care stocks experienced one or more of these feelings over the past few days.
Teva Pharmaceutical Industries Ltd (ADR) (TEVA): Hedge Funds and Insiders Are Bearish, What Should You Do?
Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) was in 47 hedge funds' portfolio at the end of March. TEVA has experienced a decrease in hedge fund sentiment of late.
GlaxoSmithKline plc (ADR) (GSK), Theravance Inc (THRX): Take a Deep Breath Before This Big FDA Decision
Every Sunday I make it a point to examine a combination of earnings stories or Food and Drug Administration panel reviews or PDUFA decisions in the upcoming week that you can'...
Hedge Funds Are Selling Novo Nordisk A/S (ADR) (NYSE:NVO) – Forest Laboratories, Inc. (NYSE:FRX), Dr. Reddy’s Laboratories Limited (ADR) (NYSE:RDY)
To most stock holders, hedge funds are assumed to be slow, outdated financial tools of the past.
Pfizer Inc. (PFE), Trius Therapeutics, Inc. (TSRX), Forest Laboratories, Inc. (FRX): Gains In This Biotech Could Soon Become Infectious to Investors
The biotech sector can occasionally throw a curveball at investors. For Trius Therapeutics, Inc.
Is Forest Laboratories, Inc. (NYSE:FRX) Going to Burn These Hedge Funds?
To most investors, hedge funds are assumed to be unimportant, outdated financial tools of yesteryear.
3 Earnings Reports That Caught My Attention Last Week: Goldman Sachs Group, Inc. (GS), Capital One Financial Corp. (COF), Forest Laboratories, Inc. (FRX)
As first-quarter earnings get ready to kick into high gear, I can't help but point out that the majority of earnings reports we've covered over the past year have been better ...
